Characteristic | Total (n = 102) | No. of USP9X positive expression cases (%) | P value |
---|---|---|---|
Age (years) | Â | Â | 0.961 |
≤59 | 60 | 24 (40.0) |  |
≥60 | 42 | 17 (40.5) |  |
Gender | Â | Â | 0.928 |
Male | 85 | 34 (40.0) | Â |
Female | 17 | 7 (41.2) | Â |
Location | Â | Â | 0.763 |
Upper | 6 | 2 (33.3) | Â |
Middle | 75 | 29 (38.7) | Â |
Lower | 21 | 10 (47.6) | Â |
Tumor length | Â | Â | 0.717 |
≤5 cm | 60 | 25 (41.7) |  |
>5Â cm | 42 | 16 (38.1) | Â |
Histological grades | Â | Â | 0.123 |
G1a | 22 | 13 (59.1) | Â |
G2a | 58 | 20 (34.5) | Â |
G3a | 22 | 8 (36.4) | Â |
Depth of invasion | Â | Â | 0.046 |
T1-T2 | 57 | 18 (31.6) | Â |
T3-T4 | 45 | 23 (51.1) | Â |
Lymph node metastasis | Â | Â | 0.032 |
Positive | 49 | 25 (51.0) | Â |
Negative | 53 | 16 (30.2) | Â |
TNM stage | Â | Â | 0.112 |
I-II | 57 | 19 (33.3) | Â |
III-IV | 45 | 22 (48.9) | Â |